Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2018143511) ORAL SUSTAINED-RELEASE TRIPLE TABLET CONTAINING PREGABALIN
Latest bibliographic data on file with the International Bureau    Submit observation

Pub. No.: WO/2018/143511 International Application No.: PCT/KR2017/003377
Publication Date: 09.08.2018 International Filing Date: 29.03.2017
IPC:
A61K 9/24 (2006.01) ,A61K 9/20 (2006.01) ,A61K 9/00 (2006.01) ,A61K 31/197 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9
Medicinal preparations characterised by special physical form
20
Pills, lozenges or tablets
22
Sustained or differential release type
24
Layered or laminated unitary dosage forms
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9
Medicinal preparations characterised by special physical form
20
Pills, lozenges or tablets
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9
Medicinal preparations characterised by special physical form
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
185
Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
19
Carboxylic acids, e.g. valproic acid
195
having an amino group
197
the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid (GABA), beta-alanine, epsilon-aminocaproic acid, pantothenic acid
Applicants:
지엘팜텍 주식회사 GL PHARMTECH CORP. [KR/KR]; 경기도 성남시 중원구 사기막골로 137 중앙인더스피아 5차 714호 #714 Jungang Induspia 5th, 137, Sagimakgol-ro, Jungwon-gu Seongnam-si Gyeonggi-do 13202, KR
Inventors:
김경훈 KIM, Kyung Hun; KR
이경수 LEE, Kyung Soo; KR
송우헌 SONG, Woo Heon; KR
박준상 PARK, Jun Sang; KR
Agent:
박종혁 PARK, Jong Hyeok; KR
Priority Data:
10-2017-001458601.02.2017KR
Title (EN) ORAL SUSTAINED-RELEASE TRIPLE TABLET CONTAINING PREGABALIN
(FR) COMPRIMÉ ORAL TRIPLE À LIBÉRATION PROLONGÉE CONTENANT DE LA PRÉGABALINE
(KO) 프레가발린 함유 경구용 서방성 삼중정제
Abstract:
(EN) Disclosed is a sustained-release three-layer tablet appropriate for administration once a day.
(FR) La présente invention concerne un comprimé à trois couches à libération prolongée approprié pour être administré une fois par jour.
(KO) 1일 1회 투여에 적합한 프레가발린 함유 서방성 삼층정제를 개시한다.
front page image
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KH, KN, KP, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (EPO) (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
Publication Language: Korean (KO)
Filing Language: Korean (KO)